Genetics in uveitis

International Ophthalmology Clinics

Volumn 45, Issue 2, 2005, Pages 15-30

  Martin, Tammy M ^a   Rosenbaum, James T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHEMOKINE; CHEMOKINE RECEPTOR; HLA B27 ANTIGEN; HLA DR15 ANTIGEN; HLA DR2 ANTIGEN; INTERFERON; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

DNA POLYMORPHISM; GENE CLUSTER; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVIEW; UVEITIS;

CYTOKINES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAJOR HISTOCOMPATIBILITY COMPLEX; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; UVEITIS;

EID: 17644411441     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000155939.83083.dd     Document Type: Review

References (121)

1. Caffrey MFP, James DCO. Human lymphocyte antigen association in ankylosing spondylitis. Nature. 1973;242:121.
2. Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1:904-907.
3. Brewerton DA, Caffrey M, Nicholls A, et al. Acute anterior uveitis and HL-A 27. Lancet. 1973;2:994-996.
4. Said-Nahal R, Miceli-Richard C, Gautreau C, et al. The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families. Ann Rheum Dis. 2002;61:201-206.
5. Malinowski SM, Pulido JS, Goeken NE, et al. The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology. 1993;100:1199-1205.
6. Oruc S, Duffy BF, Mohanakumar T, et al. The association of HLA class II with pars planitis. Am J Ophthalmol. 2001;131:657-659.
7. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology. 1999;106:594-599.
8. Greiner KH, Wilson DW, Thomson J, et al. Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis. Eur J Ophthalmol. 2003;13:433-438.
9. Alaez C, Arellanes L, Vazquez A, et al. Classic pars planitis: strong correlation of class II genes with gender and some clinical features in Mexican Mestizos. Hum Immunol. 2003;64:965-972.
10. Kenealy SJ, Pericak-Vance MA, Haines JL. The genetic epidemiology of multiple sclerosis. J Neuroimmunol. 2003;143:7-12.
11. Davey MP, Rosenbaum JT. The human leukocyte antigen complex and chronic ocular inflammatory disorders. Am J Ophthalmol. 2000;129:235-243.
12. Yabuki K, Inoko H, Ohno S. HLA testing in patients with uveitis. Int Ophthalmol Clin. 2000;40:19-35.
13. Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci. 2003;44:653-657.
14. Stephens HA. MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol. 2001;22:378-385.
15. Fu Y, Yan G, Shi L, et al. Antigen processing and autoimmunity. Evaluation of mRNA abundance and function of HLA-linked genes. Ann NY Acad Sci. 1998;842:138-155.
16. Santos Lacomba M, Marcos Martin C, Gallardo Galera JM, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res. 2001;33:251-255.
17. Perez-Guijo V, Santos-Lacomba M, Sanchez-Hernandez M, et al. Tumour necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27. Curr Med Res Opin. 2004;20:155-157.
18. Ahmad T, Wallace GR, James T, et al. Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. 2003;48: 807-813.
19. Karasneh J, Hajeer AH, Barrett J, et al. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behçet's disease. Rheumatology (Oxford). 2003;42:860-864.
20. McGarry F, Neilly J, Anderson N, et al. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford). 2001;40:1359-1364.
21. Ravindran JS, Owen P, Lagan A, et al. Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford). 2004;43:22-26.
22. van der Paardt M, Crusius JB, Garcia-Gonzalez MA, et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford). 2002;41:1419-1423.
23. Carter MJ, Jones S, Camp NJ, et al. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun. 2004;5:8-15.
24. Epplen C, Jackel S, Santos EJ, et al. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol. 1997;41:341-352.
25. Miterski B, Jaeckel S, Epplen JT, et al. The interferon gene cluster: a candidate region for MS predisposition? Multiple Sclerosis Study Group. Genes Immun. 1999;1:37-44.
26. Akahoshi M, Ishihara M, Remus N, et al. Association between IFNA genotype and the risk of sarcoidosis. Hum Genet. 2004;114:503-509.
27. Cogrel O, Doutre MS, Marliere V, et al. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. Br J Dermatol. 2002; 146:320-324.
28. Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol. 2002;107:133-144.
29. Kotter I, Gunaydin I, Zierhut M, et al. The use of interferon alpha in Behcet's disease: review of the literature. Semin Arthritis Rheum. 2004;33:320-335.
30. Kotter I, Vonthein R, Zierhut M, et al. Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behcet's disease: results of an open 4-center trial. Semin Arthritis Rheum. 2004;33:311-319.
31. Guex-Crosier Y, Wittvver AJ, Roberge FG. Intraocular production of a cytokine (CINC) responsible for neutrophil infiltration in endotoxin induced uveitis. Br J Ophthalmol. 1996;80:649-653.
32. Tuaillon N, Shen de F, Berger RB, et al. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2002;43:1493-1498.
33. Crane IJ, McKillop-Smith S, Wallace CA, et al. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2001;42:1547-1552.
34. Crane IJ, Xu H, Manivannan A, et al. Effect of anti-macrophage inflammatory protein-1alpha on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis. Eur J Immunol. 2003;33:402-410.
35. Ohta K, Yamagami S, Wiggert B, et al. Chemokine gene expression in iris-ciliary body during experimental autoimmune uveoretinitis. Curr Eye Res. 2002;24:451-457.
36. Adamus G, Manczak M, Machnicki M. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE. Invest Ophthalmol Vis Sci. 2001;42:2894-2903.
37. Manczak M, Jiang S, Orzechowska B, et al. Crucial role of CCL3/MIP-1alpha in the recurrence of autoimmune anterior uveitis induced with myelin basic protein in Lewis rats. J Autoimmun. 2002;18:259-270.
38. Fang IM, Yang CH, Lin CP, et al. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res. 2004;78:1043-1035.
39. Foxman EF, Zhang M, Hurst SD, et al. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol. 2002;168:2483-2492.
40. Gilger BC, Yang P, Salmon JH, et al. Expression of a chemokine by ciliary body epithelium in horses with naturally occurring recurrent uveitis and in cultured ciliary body epithelial cells. Am J Vet Res. 2002;63:942-947.
41. Silverman M, Zamora D, Pan Y, et al. Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. Invest Ophthalmol Vis Sci. 2003;44:1608-1615.
42. Kaburaki T, Fujino Y, Kawashima H, et al. Plasma and whole-blood chemokine levels in patients with Behcet's disease. Graefes Arch Clin Exp Ophthalmol. 2003;241:353-358.
43. Klitgaard TL, Ogard C, Krogh E. Chemokine receptors and early activation markers in acute anterior uveitis. Acta Ophthalmol Scand. 2004;82:179-183.
44. Chen Y, Vaughan RW, Kondeatis E, et al. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens. 2004;63:41-45.
45. Wallace GR, Chen Y, Vaughan R, et al. CX3CR1 I249M280 haplotype is associated with retinal vasculitis in UK patients. Invest Ophthalmol Vis Sci. 2004;403:ARVO E-abstract 3374.
46. Faure S, Meyer L, Costagliola D, et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science. 2000;287:2274-2277.
47. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19-20.
48. Blau E. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689-693.
49. Jabs DA, Houk JL, Bias WB, et al. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med. 1985;78:801-804.
50. Miller JJ 3rd. Early-onset "sarcoidosis" and "familial granulomatous arthritis (arteritis)": the same disease. J Pediatr. 1986;109:387-388.
51. Latkany P, Jabs D, Smith J, et al. Multifocal choroiditis in patients with familial juvenile systemic granulomatosis. Am J Ophthalmol. 2002;134:897-904.
52. Wang X, Kuivaniemi H, Bonavita G, et al. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 2002;46:3041-3045.
53. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869-8872.
54. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 2003;278:5509-5512.
55. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem. 2001;276:4812-4818.
56. Damiano JS, Oliveira V, Welsh K, et al. Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem J. 2004; 381:213-219.
57. Hampe J, Cuthbert A, Croucher PJP, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 2001; 357:1925-1928.
58. Hugot J-P, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
59. Ogura Y, Bonen D, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
60. Rosenbaum JT, Planck SR, Davey MP, et al. With a mere nod, uveitis enters a new era. Am J Ophthalmol. 2003;136:729-732.
61. Doyle TM, Collins JF, Rajska BM, et al. Surprising absence of CARD15/NOD2 mutations in patients with uveitis associated with Crohn's disease. Invest Ophthalmol Vis Sci. 2004;352:ARVO E-abstract 2688.
62. Martin TM, Doyle TM, Smith JR, et al. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol. 2003;136:933-935.
63. Crane AM, Bradbury L, Van Heel DA, et al. Role of NOD2 variants in spondylarthritis. Arthritis Rheum. 2002;46:1629-1633.
64. D'Amato M. The Crohn's associated NOD2 3020InsC frameshift mutation does not confer susceptibility to ankylosing spondylitis. J Rheumatol. 2002;29:2470-2471.
65. Ferreiros-Vidal I, Amarelo J, Barros F, et al. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease. J Rheumatol. 2003;30:102-104.
66. Miceli-Richard C, Zouali H, Lesage S, et al. CARD15/NOD2 analyses in spondyloarthropathy. Arthritis Rheum. 2002;46:1405-1406.
67. van der Paardt M, Crusius JB, de Koning MH, et al. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun. 2003;4:77-78.
68. Schurmann M, Valentonyte R, Hampe J, et al. CARD15 gene mutations in sarcoidosis. Eur Respir J. 2003;22:748-754.
69. Borgiani P, Vallo L, D'Apice MR, et al. Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur J Dermatol. 2002;12:540-542.
70. Young C, Allen MH, Cuthbert A, et al. A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis. Exp Dermatol. 2003;12:506-509.
71. Nair RP, Stuart P, Ogura Y, et al. Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. J Invest Dermatol. 2001;117:1671-1672.
72. Sawcer S, Maranian M, Hensiek A, et al. Crohn's associated NOD2 gene variants are not involved in determining susceptibility to multiple sclerosis. J Neurol Neurosurg Psychiatry. 2003;74:1157.
73. Ferreiros-Vidal I, Garcia-Meijide J, Carreira P, et al. The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus. Rheumatology (Oxford). 2003;42:570-574.
74. Steer S, Fisher SA, Fife M, et al. Development of rheumatoid arthritis is not associated with two polymorphisms in the Crohn's disease gene CARD15. Rheumatology (Oxford). 2003;42:304-307.
75. Newman B, Rubin LA, Siminovitch KA. NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis. J Rheumatol. 2003;30:305-307.
76. Rahman P, Bartlett S, Siannis F, et al. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet. 2003;73:677-681.
77. Giardina E, Novelli G, Costanzo A, et al. Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. J Invest Dermatol. 2004;122:1106-1107.
78. Croucher PJ, Mascheretti S, Hampe J, et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet. 2003;11:6-16.
79. Guo QS, Xia B, Jiang Y, et al. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol. 2004;10:1069-1071.
80. Sugimura M, Kinouchi Y, Takahashi S, et al. CARD15/NOD2 mutational analysis in Japanese patients with Crohn's disease. Clin Genet. 2003;63:160-162.
81. Yamazaki K, Takazoe M, Tanaka T, et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002;47:469-472.
82. Harton J, Linhoff M, Zhang J, et al. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol. 2002;169:4088-4093.
83. Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46:3340-3348.
84. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol. 2003;4:95-104.
85. Neven B, Callebaut I, Prieur AM, et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood. 2004;103:2809-2815.
86. Haas N, Kuster W, Zuberbier T, et al. Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol. 2004; 151:99-104.
87. Porksen G, Lohse P, Rosen-Wolff A, et al. Periodic fever, mild arthralgias, and reversible moderate and severe organ inflammation associated with the V198M mutation in the CIAS1 gene in three German patients - expanding phenotype of CIAS1 related autoinflammatory syndrome. Eur J Haematol. 2004;73:123-127.
88. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell. 2004;117:561-574.
89. Cornelis F, Faure S, Martinez M, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA. 1998;95:10746-10750.
90. Eyre S, Barton A, Shephard N, et al. Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs. Arthritis Rheum. 2004;50:729-735.
91. MacKay K, Eyre S, Myerscough A, et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 2002;46:632-639.
92. Gaffney PM, Kearns GM, Shark KB, et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA. 1998;95:14875-14879.
93. Moser KL, Neas BR, Salmon JE, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA. 1998;95:14869-14874.
94. Shai R, Quismorio FP Jr, Li L, et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet. 1999;8:639-644.
95. Tsao BP, Cantor RM, Kalunian KC, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest. 1997;99:725-731.
96. Allen EM, Hsueh WC, Sabra MM, et al. A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: replication of genetic linkage on chromosome 5q11.2-q14.3. J Clin Endocrinol Metab. 2003;88:1292-1296.
97. Maalej A, Makni H, Ayadi F, et al. A full genome screening in a large Tunisian family affected with thyroid autoimmune disorders. Genes Immun. 2001;2:71-75.
98. Tomer Y, Ban Y, Concepcion E, et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet. 2003;73:736-747.
99. Villanueva R, Tomer Y, Greenberg DA, et al. Autoimmune thyroid disease susceptibility loci in a large Chinese family. Clin Endocrinol (Oxf). 2002;56:45-51.
100. Alkhateeb A, Stetler GL, Old W, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet. 2002;11:661-667.
101. Cox NJ, Wapelhorst B, Morrison VA, et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet. 2001;69:820-830.
102. Mein CA, Esposito L, Dunn MG, et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet. 1998;19:297-300.
103. Vaessen N, Heutink P, Houwing-Duistermaat JJ, et al. A genome-wide search for linkage-disequilibrium with type 1 diabetes in a recent genetically isolated population from the Netherlands. Diabetes. 2002;51:856-859.
104. Nair R, Henseler T, Jenisch S, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet. 1997;6:1349-1356.
105. Sagoo GS, Tazi-Ahnini R, Barker JW, et al. Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. J Invest Dermatol. 2004;122:1401-1405.
106. Samuelsson L, Enlund F, Torinsson A, et al. A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach. Hum Genet. 1999; 105:523-529.
107. Trembath RC, Clough RL, Rosbotham JL, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet. 1997;6:813-820.
108. Hampe J, Schreiber S, Shaw SH, et al. A genome-wide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet. 1999;64:808-816.
109. Paavola P, Helio T, Kiuru M, et al. Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21. Eur J Hum Genet. 2001;9:328-334.
110. Rioux JD, Silverberg MS, Daly MJ, et al. Genome-wide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet. 2000;66:1863-1870.
111. Satsangi J, Parkes M, Louis E, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 1996;14:199-202.
112. Tromp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet. 1996;59:1097-1107.
113. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nat Genet. 1996;13:472-476.
114. Kuokkanen S, Gschwend M, Rioux JD, et al. Genome-wide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet. 1997;61:1379-1387.
115. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet. 1996;13:464-468.
116. Schurmann M, Reichel P, Muller-Myhsok B, et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med. 2001;164:840-846.
117. Brown MA, Pile KD, Kennedy LG, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum. 1998;41:588-595.
118. Laval SH, Timms A, Edwards S, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet. 2001;68: 918-926.
119. Zhang G, Luo J, Bruckel J, et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 2004;50:2246-2254.
120. Miceli-Richard C, Zouali H, Said-Nahal R, et al. Significant linkage to spondyloarthropathy on 9q31-34. Hum Mol Genet. 2004;13:1641-1648.
121. Martin TM, Zhang G, Luo J, et al. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum. 2005;52:269-274.